Sysmex America, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$3.0M
Doctors Paid
177
Transactions
839
2024 Total
$54,427
Payment Breakdown by Category
Research$1.9M (65.0%)
Consulting$755,506 (25.6%)
Travel$67,590 (2.3%)
Food & Beverage$14,733 (0.5%)
Royalty/License$2,000 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.9M | 86 | 65.0% |
| Consulting Fee | $755,506 | 116 | 25.6% |
| Honoraria | $118,680 | 68 | 4.0% |
| Travel and Lodging | $67,590 | 223 | 2.3% |
| Charitable Contribution | $30,050 | 11 | 1.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,496 | 9 | 0.8% |
| Food and Beverage | $14,733 | 300 | 0.5% |
| Education | $10,350 | 3 | 0.4% |
| Space rental or facility fees (teaching hospital only) | $9,099 | 7 | 0.3% |
| Royalty or License | $2,000 | 2 | 0.1% |
| Gift | $1,714 | 14 | 0.1% |
Payments by Type
Research
$1.9M
86 transactions
General
$1.0M
753 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Development of lipoprotein function assay for cardiovascular risk evaluation | $298,302 | 0 | 3 |
| XW-100 Study | $192,118 | 0 | 13 |
| Association of Platelet Parameters Identified by the Sysmex XN-1000 and Flow Cytometry with Concurrent and Subsequent Bleeding Severity in Children with Immune Thrombocytopenia | $133,646 | 0 | 4 |
| Fibrosis of Liver Study | $120,344 | 0 | 5 |
| UC-3500 Fully Automated Urine Chemistry Analyzer Protocol | $102,232 | 0 | 6 |
| XN Series Study | $100,000 | 0 | 2 |
| XQ Series Automated Hematology Analyzers - Evaluation Protocol (XQ320-01) | $94,554 | 0 | 2 |
| MI-FCM Study | $92,381 | 0 | 2 |
| Significance of advanced CBC parameters in diagnostic work-up of myeloid neoplasms | $91,218 | 0 | 6 |
| XR Series (XR-10, XR-20) Automated Hematology Analyzers - Evaluation Protocol (XR10/20-01) | $83,770 | 0 | 1 |
| XN-10 Automated Hematology Analyzer with Blood Bank Mode - WBC Supplemental Studies Protocol (XNBB-03) | $73,187 | 0 | 2 |
| Sysmex UD-10 Fully Automated Urine Particle Digital Imaging Device - Design Validation Protocol | $66,875 | 0 | 6 |
| Clinical Evaluation of Advanced Hematology Parameters: Arm 1: The Automated Anemia Algorith; Arm 2: Cellular Alert for Prediction of Sepsis | $63,028 | 0 | 1 |
| Reticulocyte Hemoglobin in management of iron deficiency anemia | $60,000 | 0 | 3 |
| XN-10 Automated Hematology Analyzer with Blood Bank Mode - Evaluation Protocol | $52,095 | 0 | 2 |
| Analytical Specificity of Synovial Fluid Cell Counts in Patients with Metal-on-Metal or Metal-on-Polyethylene Joint Replacements | $47,662 | 0 | 3 |
| UC-3500 Fully Automated Urine Chemistry Design Verification Protocol | $44,104 | 0 | 2 |
| Defining Normal Newborn Automated Hematological Reference Intervals | $38,640 | 0 | 2 |
| XN-L Evaluation Protocol | $35,174 | 0 | 5 |
| UC-3500 Fully Automated Urine Chemistry Analyzer - Clinical Evaluation Protocol Supplemental Studies | $21,616 | 0 | 2 |
| UC-3500 Fully Automated Urine Chemistry Analyzer - Design Validation Protocol | $20,309 | 0 | 1 |
| Reticulocyte Hemoglobin as a Predictive Biomarker of Early Brain Iron Deficiency | $16,265 | 0 | 2 |
| TBI Study | $12,000 | 0 | 1 |
| Immature granulocyte (IG) counts as a predictor of severe sepsis and septic shock | $10,542 | 0 | 1 |
| ALTERNATIVE QC PROTOCOL AND STUDY FOR SYSMEX ANALYZERS | $9,950 | 0 | 1 |
| Stratification of Bleeding Risk in Children with Immune Thrombocytopenia Using Platelet Function Testing | $9,000 | 0 | 1 |
| Reticulocyte Hemoglobin (RET-He) as a Predictive Biomarker of Early Brain Iron Deficiency | $6,162 | 0 | 1 |
| XN Study | $6,114 | 0 | 1 |
| The IPF as a marker of megakaryopoiesis in neonatal and adult models of thrombocytopenia | $6,061 | 0 | 1 |
| XN Study 5 | $5,485 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 8
No doctor payment records found.
Ad
Top Products
- XN Series $767,821
- AUTOMATED HEMATOLOGY ANALYZER XN SERIES XN-10 $564,807
Associated Products (13)
- XN Series $767,821
- AUTOMATED HEMATOLOGY ANALYZER XN SERIES XN-10 $564,807
- HISCL $418,784
- XW-100 $192,118
- UC Series $112,313
- MI-FCM $92,381
- XR-10 $83,770
- UC-3500 $77,569
- UD-10 $66,875
- XN-L Series $35,174
- C-FCM $21,119
- Tau/P-Tau Antibodies $12,000
- XF-1600 $10,915
Payment Categories
- Food & Beverage $14,733
- Consulting $755,506
- Travel & Lodging $67,590
- Research $1.9M
- Royalties $2,000
About Sysmex America, Inc.
Sysmex America, Inc. has made $3.0M in payments to 177 healthcare providers, recorded across 839 transactions in the CMS Open Payments database. In 2024, the company paid $54,427. The top product by payment volume is XN Series ($767,821).
Payments were distributed across 36 medical specialties. The top specialty by payment amount is Anatomic Pathology ($333,749 to 6 doctors).
Payment categories include: Food & Beverage ($14,733), Consulting ($755,506), Research ($1.9M), Travel & Lodging ($67,590), Royalties ($2,000).
Sysmex America, Inc. is associated with 13 products in the CMS Open Payments database, including XN Series, AUTOMATED HEMATOLOGY ANALYZER XN SERIES XN-10, and HISCL.